申请人:SmithKline Beecham Corporation
公开号:US06262113B1
公开(公告)日:2001-07-17
The present invention relates to novel compounds and a novel use of phenyl ureas in the treatment of disease states mediated by the chemokine Interleukin-8 (IL-8).
本发明涉及新化合物以及苯基脲在治疗由趋化因子白细胞介素-8(IL-8)介导的疾病状态中的新用途。